Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Author Correction: Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis.
Casanova AG, Roth GS, Hausmann S, Lu X, Bischoff LJM, Froeliger EM, Belmudes L, Bourova-Flin E, Flores NM, Benitez AM, Chasan T, Caporicci M, Vayr J, Blanchet S, Ielasi F, Rousseaux S, Hainaut P, Gozani O, Le Romancer M, Couté Y, Palencia A, Mazur PK, Reynoird N. Casanova AG, et al. Among authors: le romancer m. Cell Discov. 2024 Mar 26;10(1):34. doi: 10.1038/s41421-024-00661-4. Cell Discov. 2024. PMID: 38531836 Free PMC article. No abstract available.
Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis.
Casanova AG, Roth GS, Hausmann S, Lu X, Bischoff LJM, Froeliger EM, Belmudes L, Bourova-Flin E, Flores NM, Benitez AM, Chasan T, Caporicci M, Vayr J, Blanchet S, Ielasi F, Rousseaux S, Hainaut P, Gozani O, Le Romancer M, Couté Y, Palencia A, Mazur PK, Reynoird N. Casanova AG, et al. Among authors: le romancer m. Cell Discov. 2024 Jan 31;10(1):12. doi: 10.1038/s41421-023-00644-x. Cell Discov. 2024. PMID: 38296970 Free PMC article.
PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer.
Noureddine LM, Ablain J, Surmieliova-Garnès A, Jacquemetton J, Pham TH, Marangoni E, Schnitzler A, Bieche I, Badran B, Trédan O, Hussein N, Le Romancer M, Poulard C. Noureddine LM, et al. Among authors: le romancer m. Life Sci Alliance. 2023 Aug 3;6(10):e202302009. doi: 10.26508/lsa.202302009. Print 2023 Oct. Life Sci Alliance. 2023. PMID: 37536978 Free PMC article.
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer.
Poulard C, Ha Pham T, Drouet Y, Jacquemetton J, Surmielova A, Kassem L, Mery B, Lasset C, Reboulet J, Treilleux I, Marangoni E, Trédan O, Le Romancer M. Poulard C, et al. Among authors: le romancer m. EMBO Mol Med. 2023 Aug 7;15(8):e17248. doi: 10.15252/emmm.202217248. Epub 2023 Jul 17. EMBO Mol Med. 2023. PMID: 37458145 Free PMC article.
A hotspot for posttranslational modifications on the androgen receptor dimer interface drives pathology and anti-androgen resistance.
Alegre-Martí A, Jiménez-Panizo A, Martínez-Tébar A, Poulard C, Peralta-Moreno MN, Abella M, Antón R, Chiñas M, Eckhard U, Piulats JM, Rojas AM, Fernández-Recio J, Rubio-Martínez J, Le Romancer M, Aytes Á, Fuentes-Prior P, Estébanez-Perpiñá E. Alegre-Martí A, et al. Among authors: le romancer m. Sci Adv. 2023 Mar 17;9(11):eade2175. doi: 10.1126/sciadv.ade2175. Epub 2023 Mar 15. Sci Adv. 2023. PMID: 36921044 Free PMC article.
PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer.
Suresh S, Huard S, Brisson A, Némati F, Dakroub R, Poulard C, Ye M, Martel E, Reyes C, Silvestre DC, Meseure D, Nicolas A, Gentien D, Fayyad-Kazan H, Le Romancer M, Decaudin D, Roman-Roman S, Dubois T. Suresh S, et al. Among authors: le romancer m. Cancers (Basel). 2022 Jan 8;14(2):306. doi: 10.3390/cancers14020306. Cancers (Basel). 2022. PMID: 35053470 Free PMC article.
88 results